Rezultaty - Umesh Chaudhari

  • Rezultaty 1 - 14 Rezultaty od 14
Redukuj rezultaty
  1. 1
    MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes

    MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes od Umesh Chaudhari, Harshal Nemade, John Antonydas Gaspar, Jürgen Hescheler, Jan G. Hengstler, Agapios Sachinidis

    Wydane 2016
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes

    Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes od Umesh Chaudhari, James K. Ellis, Vilas Wagh, Harshal Nemade, Jürgen Hescheler, Hector C. Keun, Agapios Sachinidis

    Wydane 2017
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

    Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODY... od Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

    Wydane 2015
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

    Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO... od Christopher P. Cannon, Bertrand Cariou, Dirk Blom, James M. McKenney, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

    Wydane 2015
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab

    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab od Jennifer G. Robinson, Robert S. Rosenson, Michel Farnier, Umesh Chaudhari, William J. Sasiela, Laurence Merlet, Kathryn Miller, John J.P. Kastelein

    Wydane 2017
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study

    PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study od Stephen R. Daniels, Sonia Caprio, Umesh Chaudhari, Garen Manvelian, Marie T. Baccara-Dinet, Aurélie Brunet, Michel Scemama, Virginie Loizeau, Éric Bruckert

    Wydane 2020
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials

    Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated... od Helen M. Colhoun, Jennifer G. Robinson, Michel Farnier, Bertrand Cariou, Dirk Blom, Dean J. Kereiakes, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

    Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer od Giancarlo Agnelli, Daniel J. George, Ajay K. Kakkar, Winfield S. Fisher, Michael R. Lassen, Patrick Mismetti, Patrick Mouret, Umesh Chaudhari, Francesca Lawson, Alexander G.G. Turpie

    Wydane 2012
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals

    Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals od Robim M. Rodrigues, Joery De Kock, Steven Branson, Mathieu Vinken, Kesavan Meganathan, Umesh Chaudhari, Agapios Sachinidis, Olivier Govaere, Tania Roskams, Veerle De Boe, Tamara Vanhaecke, Vera Rogiers

    Wydane 2013
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment

    Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety asses... od Umesh Chaudhari, Harshal Nemade, Vilas Wagh, John Antonydas Gaspar, James K. Ellis, Sureshkumar Perumal Srinivasan, Dimitry Spitkovski, Filomain Nguemo, Jochem Louisse, Susanne Bremer, Jürgen Hescheler, Hector C. Keun, Jan G. Hengstler, Agapios Sachinidis

    Wydane 2015
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  11. 11
    Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events od Jennifer G. Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S.G. Stroes, Gisle Langslet, Frederick J. Raal, Mahfouz El Shahawy, Michael J. Koren, Norman E. Lepor, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, John J.P. Kastelein

    Wydane 2015
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  12. 12
    Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells

    Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells od Patrício Godoy, Wolfgang Schmidt‐Heck, Karthick Natarajan, Baltasar Lucendo‐Villarin, Dagmara Szkolnicka, Annika Asplund, Petter Björquist, Agata Widera, Regina Stöber, Gisela Campos, Seddik Hammad, Agapios Sachinidis, Umesh Chaudhari, Georg Damm, Thomas S. Weiß, Andreas K. Nüssler, Jane Synnergren, Karolina Edlund, Barbara Küppers-Munther, David C. Hay, Jan G. Hengstler

    Wydane 2015
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  13. 13
    Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue

    Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue od Patrício Godoy, Agata Widera, Wolfgang Schmidt‐Heck, Gisela Campos, Christoph Meyer, Cristina Cadenas, Raymond Reif, Regina Stöber, Seddik Hammad, Larissa Pütter, Kathrin Gianmoena, Rosemarie Marchan, Ahmed Ghallab, Karolina Edlund, Andreas K. Nüssler, Wolfgang E. Thasler, Georg Damm, Daniel Seehofer, Thomas S. Weiß, Olaf Dirsch, Uta Dahmen, Rolf Gebhardt, Umesh Chaudhari, Kesavan Meganathan, Agapios Sachinidis, Jens M. Kelm, Ute Hofmann, René P. Zahedi, Reinhard Guthke, Nils Blüthgen, Steven Dooley, Jan G. Hengstler

    Wydane 2016
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  14. 14
    Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

    Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease:... od Ahmet Özen, Voranush Chongsrisawat, Asena Pınar Sefer, Burcu Kolukısa, Jessica J. Jalbert, Karoline A. Meagher, Taylor Brackin, Hagit Baris Feldman, Safa Barış, Elif Karakoç-Aydıner, Rabia Ergelen, Ivan J. Fuss, Heather Moorman, Narissara Suratannon, Kanya Suphapeetiporn, Lorah Perlee, Olivier Harari, George D. Yancopoulos, Michael J. Lenardo, Jutta Miller, Orly Eshach Adiv, Sevgi Bilgiç Eltan, Melek Yorgun Altunbaş, Mary Magliocco, Helen Matthews, Beatriz E. Marciano, Pantipa Chatchatee, Caryn F. Trbovic, Michael E. Burczynski, Umesh Chaudhari, Yusuf Usta, Cansu Altuntaş, Sibel Yavuz, Abdulkadir Baştürk, Fatma Demirbaş, Erdem Topal, Ayhan Gazi Kalaycı, Wanlapa Weerapakorn, A MARTINEZ, Adriana Bottero

    Wydane 2024
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: